Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSBS.L Regulatory News (SBS)

  • There is currently no data for SBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Source Bioscience Plc

10 Aug 2016 09:22

RNS Number : 7858G
Nplus1 Singer Capital Markets Ltd
10 August 2016
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED IN,TERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nplus1 Singer Capital Markets Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

Source Bioscience Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

 

Source Bioscience Plc

(d) Date dealing undertaken:

9 August 2016

 

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

Yes

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 2P

 

Purchase

 

404,922

 

17.85p

 

17.655p

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

Date of disclosure:

10 August 2016

Contact name:

Reema Maru

Telephone number:

020 7496 3094

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERAKKDBFBKKKFD
Date   Source Headline
8th Sep 20156:20 pmRNSDirector/PDMR Shareholding
28th Aug 20152:53 pmRNSHolding(s) in Company
25th Aug 20157:02 amRNSHalf Yearly Report
25th Aug 20157:00 amRNSNon-Executive Director Changes
19th Aug 201510:25 amRNSHolding(s) in Company
17th Aug 201510:05 amRNSCompletion of Acquisition
14th Aug 201511:00 amRNSResult of General Meeting
13th Aug 20153:20 pmRNSHolding(s) in Company
10th Aug 201510:52 amRNSHolding(s) in Company
10th Aug 201510:43 amRNSHolding(s) in Company
30th Jul 20157:00 amRNSPosting of Class 1 Circular and Notice of GM
27th Jul 20157:00 amRNSProposed Acqn of Select Pharma Laboratories Ltd
29th Jun 20153:41 pmRNSResult of AGM
11th Jun 20159:00 amRNSAGM Statement
15th May 20159:00 amRNSNotice of AGM
30th Apr 201510:53 amRNSTotal Voting Rights
27th Apr 20152:35 pmRNSAdditional Listing
31st Mar 201510:22 amRNSHolding(s) in Company
25th Mar 20157:00 amRNSFinal Results
11th Mar 20152:57 pmRNSNotice of Results
10th Mar 20151:05 pmRNSHolding(s) in Company
10th Mar 201512:51 pmRNSHolding(s) in Company
29th Jan 201510:15 amRNSHolding(s) in Company
29th Jan 201510:00 amRNSHolding(s) in Company
23rd Jan 201510:00 amRNSHolding(s) in Company
23rd Jan 20159:45 amRNSHolding(s) in Company
22nd Jan 201510:23 amRNSHolding(s) in Company
21st Jan 20157:00 amRNSTrading Update
20th Jan 20159:43 amRNSHolding(s) in Company
16th Jan 201510:10 amRNSHolding(s) in Company
16th Jan 201510:00 amRNSHolding(s) in Company
7th Jan 201511:55 amRNSHolding(s) in Company
7th Jan 201511:46 amRNSHolding(s) in Company
21st Oct 201410:22 amRNSHolding(s) in Company
1st Oct 201410:23 amRNSHolding(s) in Company
4th Sep 20147:00 amRNSAppointment to the Board
20th Aug 20147:00 amRNSHalf Yearly Report
3rd Jul 20147:00 amRNSAppointment to the Board
30th Jun 20145:30 pmRNSTotal Voting Rights
23rd Jun 201412:47 pmRNSAdditional Listing
12th Jun 20147:00 amRNSAGM Statement
19th May 20149:00 amRNSHolding(s) in Company
19th May 20147:00 amRNSInterim Management Statement
16th May 201411:30 amRNSHolding(s) in Company
14th May 201410:00 amRNSNotice of AGM
2nd Apr 20149:01 amRNSHolding(s) in Company
1st Apr 20147:00 amRNSLaunch of Products and Services in the USA
18th Mar 20147:00 amRNSFinal Results
6th Mar 20147:00 amRNSNotice of Results
31st Jan 20149:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.